# FDA Inspection 1257699 - Konapharma AG - June 19, 2024

Source: https://www.globalkeysolutions.net/records/fda_inspections/konapharma-ag/7f271ab8-7c1a-4d04-b06b-fb46d1aa8092
Source feed: FDA_Inspections

> FDA Inspection 1257699 for Konapharma AG on June 19, 2024. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1257699
- Company Name: Konapharma AG
- Inspection Date: 2024-06-19
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1059703 - 2018-06-22](https://www.globalkeysolutions.net/records/fda_inspections/konapharma-ag/fcc2ab15-1bae-4ee9-9ceb-c3d7c155af3c)
- [FDA Inspection 957960 - 2016-01-22](https://www.globalkeysolutions.net/records/fda_inspections/konapharma-ag/3b027e88-e3a6-45cf-b8e9-0cce67449d03)
- [FDA Inspection 827273 - 2013-04-17](https://www.globalkeysolutions.net/records/fda_inspections/konapharma-ag/a492afb8-37cf-4983-90e8-4265c2a7db06)
- [FDA Inspection 619086 - 2009-09-15](https://www.globalkeysolutions.net/records/fda_inspections/konapharma-ag/372ef40e-e625-4343-b15a-5d531ec8c1d6)

Company: https://www.globalkeysolutions.net/companies/konapharma-ag/1ef1b930-e6b0-4f43-ae72-44e971cdfa84

Office: https://www.globalkeysolutions.net/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c